Trial intelligence / Profile preview

SKL11197 for Pain of Diabetic Peripheral Neuropathy

NCT01521598Phase 2Completed

Sponsor
SK Life Science, Inc.
Start
Jan 2012
Primary completion
Jun 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of SKL11197 in diabetic peripheral neuropathy (DPN), sponsored by SK Life Science, Inc.. Started Jan 2012; status: completed.

02

Drugs

SKL11197
03

Conditions

diabetic peripheral neuropathy (DPN)

Beyond the preview

Go deeper on NCT01521598.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01521598.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call